Atcher R - Search Results

1

Synthesis and Preliminary Biological Evaluations of Fluorescent or ¹⁴⁹Promethium Labeled Trastuzumab-Polyethylenimine.

Fitzsimmons J, Nayak T, Cutler C, Atcher R. Fitzsimmons J, et al. Among authors: atcher r. Biomedicines. 2015 Dec 30;4(1):1. doi: 10.3390/biomedicines4010001. Biomedicines. 2015. PMID: 28536369 Free PMC article.

2

Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.

Nayak TK, Norenberg JP, Anderson TL, Prossnitz ER, Stabin MG, Atcher RW. Nayak TK, et al. Among authors: atcher rw. Nucl Med Biol. 2007 Feb;34(2):185-93. doi: 10.1016/j.nucmedbio.2006.11.006. Nucl Med Biol. 2007. PMID: 17307126

3

Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation.

Nayak TK, Atcher RW, Prossnitz ER, Norenberg JP. Nayak TK, et al. Among authors: atcher rw. Nucl Med Biol. 2008 Aug;35(6):673-8. doi: 10.1016/j.nucmedbio.2008.05.003. Nucl Med Biol. 2008. PMID: 18678352 Free PMC article.

4

Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.

Nayak TK, Dennis MK, Ramesh C, Burai R, Atcher RW, Sklar LA, Norenberg JP, Hathaway HJ, Arterburn JB, Prossnitz ER. Nayak TK, et al. Among authors: atcher rw. ACS Chem Biol. 2010 Jul 16;5(7):681-90. doi: 10.1021/cb1000636. ACS Chem Biol. 2010. PMID: 20486699 Free PMC article.

5

A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.

Nayak T, Norenberg J, Anderson T, Atcher R. Nayak T, et al. Among authors: atcher r. Cancer Biother Radiopharm. 2005 Feb;20(1):52-7. doi: 10.1089/cbr.2005.20.52. Cancer Biother Radiopharm. 2005. PMID: 15778581

6

Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations.

Makvandi M, Dupis E, Engle JW, Nortier FM, Fassbender ME, Simon S, Birnbaum ER, Atcher RW, John KD, Rixe O, Norenberg JP. Makvandi M, et al. Among authors: atcher rw. Target Oncol. 2018 Apr;13(2):189-203. doi: 10.1007/s11523-018-0550-9. Target Oncol. 2018. PMID: 29423595 Review.

7

Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.

Su FM, Beaumier P, Axworthy D, Atcher R, Fritzberg A. Su FM, et al. Among authors: atcher r. Nucl Med Biol. 2005 Oct;32(7):741-7. doi: 10.1016/j.nucmedbio.2005.06.009. Nucl Med Biol. 2005. PMID: 16243650

8

G2M arrest and apoptosis in murine T lymphoma cells following exposure to 212Bi alpha particle irradiation.

Palayoor ST, Humm JL, Atcher RW, Hines JJ, Macklis RM. Palayoor ST, et al. Among authors: atcher rw. Nucl Med Biol. 1993 Aug;20(6):795-805. doi: 10.1016/0969-8051(93)90166-r. Nucl Med Biol. 1993. PMID: 8401380

9

Improved safety and efficacy of ²¹³Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine.

Chan HS, Konijnenberg MW, Daniels T, Nysus M, Makvandi M, de Blois E, Breeman WA, Atcher RW, de Jong M, Norenberg JP. Chan HS, et al. Among authors: atcher rw. EJNMMI Res. 2016 Dec;6(1):83. doi: 10.1186/s13550-016-0240-5. Epub 2016 Nov 21. EJNMMI Res. 2016. PMID: 27873240 Free PMC article.

10

Increased nuclear damage by high linear energy transfer radioisotopes applicable for radiodirected therapy against radiologic malignancies.

Rotmensch J, Schwartz JL, Atcher RW, Harper PV, DeSombre E. Rotmensch J, et al. Among authors: atcher rw. Gynecol Obstet Invest. 1991;32(3):180-4. doi: 10.1159/000293025. Gynecol Obstet Invest. 1991. PMID: 1757000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters